Real ‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group

Hepatology Research,Volume 0, Issue ja, -Not available-.

Source: Hepatology Research - September 1, 2018 Category: Internal Medicine Authors: TakehiroAkahane , MasayukiKurosaki , JunItakura , KeijiTsuji , KoujiJoko , HiroyukiKimura , AkihiroNasu , ChikaraOgawa , YujiKojima , ChitomiHasebe , ShuichiWada , YasushiUchida , TetsuroSohda , HideyukiSuzuki , HideoYoshida , Source Type: research